Immunome Inc (IMNM)
12.82
+1.23
(+10.61%)
USD |
NASDAQ |
Nov 04, 16:00
12.84
+0.02
(+0.12%)
Pre-Market: 20:00
Immunome Price to Book Value: 3.033 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.033 |
| November 01, 2024 | 2.742 |
| October 31, 2024 | 2.714 |
| October 30, 2024 | 2.886 |
| October 29, 2024 | 2.886 |
| October 28, 2024 | 2.941 |
| October 25, 2024 | 2.865 |
| October 24, 2024 | 2.841 |
| October 23, 2024 | 2.744 |
| October 22, 2024 | 2.770 |
| October 21, 2024 | 2.818 |
| October 18, 2024 | 2.905 |
| October 17, 2024 | 2.860 |
| October 16, 2024 | 2.920 |
| October 15, 2024 | 2.882 |
| October 14, 2024 | 2.874 |
| October 11, 2024 | 2.893 |
| October 10, 2024 | 2.808 |
| October 09, 2024 | 2.91 |
| October 08, 2024 | 3.052 |
| October 07, 2024 | 2.946 |
| October 04, 2024 | 3.116 |
| October 03, 2024 | 3.177 |
| October 02, 2024 | 3.194 |
| October 01, 2024 | 3.199 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.459 |
| September 27, 2024 | 3.402 |
| September 26, 2024 | 3.393 |
| September 25, 2024 | 3.374 |
| September 24, 2024 | 3.456 |
| September 23, 2024 | 3.312 |
| September 20, 2024 | 3.546 |
| September 19, 2024 | 3.617 |
| September 18, 2024 | 3.667 |
| September 17, 2024 | 3.643 |
| September 16, 2024 | 3.736 |
| September 13, 2024 | 3.778 |
| September 12, 2024 | 3.480 |
| September 11, 2024 | 3.421 |
| September 10, 2024 | 3.461 |
| September 09, 2024 | 3.459 |
| September 06, 2024 | 3.203 |
| September 05, 2024 | 3.364 |
| September 04, 2024 | 3.480 |
| September 03, 2024 | 3.322 |
| August 30, 2024 | 3.591 |
| August 29, 2024 | 3.606 |
| August 28, 2024 | 3.674 |
| August 27, 2024 | 3.542 |
| August 26, 2024 | 3.717 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7173
Minimum
May 13 2022
75.46
Maximum
Dec 28 2023
7.828
Average
3.633
Median
Apr 17 2024
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.006 |
| AIM ImmunoTech Inc | 2.666 |
| IGC Pharma Inc | 3.617 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 3.294 |
Price to Book Value Related Metrics
| PS Ratio | 37.36 |
| Price | 12.82 |
| Earnings Yield | -122.1% |
| Market Cap | 769.90M |